Program Leadership for Life Sciences
Leading Development Programs from Strategy to Submission
Every day counts for your patients, your drug, and your business.
Archentis Partners provides strategic leadership and execution architecture for biotechnology and pharmaceutical development programs—aligning strategy, cross-functional execution, and governance to advance assets with confidence.
Services
Program Strategy & planning
We translate scientific strategy into structured integrated development plans and target product profiles—aligning regulatory pathways, clinical milestones, and program execution to maximize value creation.
Development Program Leadership
We provide executional and strategic leadership for development teams —aligning teams, clarifying milestones, and driving key decisions. Our model integrates governance, risk mitigation, and cross-functional accountability to advance programs with precision.
Operations & alliance Management
We oversee external partnerships and development operations to ensure vendors, CROs, CDMOs, and collaborators operate in alignment with program objectives by building strong relationships to drive success.
Regulatory Submission Governance
We provide regulatory program leadership to guide complex submissions and development milestones. Through structured planning, cross-functional alignment, and proactive risk management, we ensure regulatory execution remains disciplined and predictable.
What Makes Archentis Different
Program Leadership as a Core Discipline
We lead development programs—not individual functions—integrating strategy, execution, and governance.
Structured Development Execution
Integrated plans, governance frameworks, and milestone-driven execution bring clarity and control to complex programs.
Focused on Critical Inflection Points
We engage when programs face complexity, risk, or key regulatory milestones.
Who We Work With
Archentis Partners works with biotechnology and pharmaceutical organizations at critical stages of development where structured program leadership and execution discipline are essential.
-
Organizations preparing to advance their first assets into the clinic or scale development operations.
-
Companies managing multiple programs and requiring stronger governance, cross-functional alignment, and execution oversight.
-
Organizations operating with outsourced models that require structured oversight of CROs, CDMOs, and strategic partners.
-
Teams preparing for major milestones, including IND/CTA submissions, clinical study start-up, or NDA/BLA preparation.
-
When investors, boards, or strategic partners require independent assessment of development programs, including evaluation of development plans, regulatory pathways, execution risk, and capital requirements. Archentis Partners provides structured diligence support to assess the feasibility, timelines, and operational readiness of development programs—informing investment decisions and portfolio strategy.
Development Leadership Across the Drug Development Lifecycle
Archentis Partners brings more than 17 years of experience leading cross-functional development programs across biotechnology and pharmaceutical organizations. We support development teams in designing integrated strategies, aligning execution, and advancing assets through key clinical and regulatory milestones.
Highlights
17+ Years in Drug Development
Experience spanning research through late-stage programs.
Integrated Development Leadership
Design and execution of integrated development plans guiding programs toward global regulatory submissions.
Broad Modality and Indication Expertise
Small molecules, biologics, rare disease, oncology, and genetic therapeutics.
Cross-Functional Program Execution
Leadership across clinical, nonclinical, regulatory, CMC, and commercial teams.
The Archentis Development Leadership Model
A Structured Approach to Program Execution
Successful drug development requires more than functional expertise—it requires disciplined leadership across strategy, governance, and execution.
The Archentis Development Leadership Model integrates development planning, program leadership, operational oversight, and regulatory execution to ensure development programs advance with clarity and control.
Our model helps organizations:
• define clear development pathways
• align cross-functional teams
• manage risk proactively
• achieve regulatory milestones with confidence